Search results for earnings
-
Posted
Mar 06 2009, 03:03 AM
by
Douglas McIntyre
Rating:
Money Blog: Top Stocks Blog - MSN Money
One of the most frequent comments made by market experts and investors now that the indexes are reaching multi-decade lows is that the market can’t keep going down forever. It allows investors to feel something beyond the overwhelming pessimism that greets them every day when trading starts.
Of course, a mathematician can show anyone that the markets can go down for a nearly infinite number of days if the decreases get smaller and smaller. For investors who want a small fraction of their investments back sometime in the next decade, this sort of academic argument may be didactic, but it has no practical use. What's likely to happen is that the market will fall another 15% or 20% and then trade sideways, perhaps for several years. That happened from 1965 to 1981.There were peaks and troughs during that stretch, and clearly traders made money on those. But it was a particularly poor period for long-term investors who wanted to buy and hold.
Read More...
-
Posted
Mar 20 2009, 03:45 AM
by
Douglas McIntyre
Rating:
Money Blog: Top Stocks Blog - MSN Money
In many large American cities, office buildings sit half finished in financial districts. Huge cranes still sit next to some of them. If the construction on a site was stopped, there is nothing left beyond a skyscraper skeleton and a security fence to keep vandals out.
As law firms, investment banks, car companies, retailers and other businesses cut jobs and move to cheaper offices, the commercial real estate industry is collapsing with astonishing speed. Few unfinished buildings are erected with cash from the developers. Banks put the money up for the physical location and structure, and perhaps even the rent from tenants, as security deposits in most cases. The land is no longer worth much. The buildings are half empty or unfinished and tenants are leaving, and, in many cases, defaulting on their leases. Lawsuits demanding payment of those obligations are long and expensive. As often as not, the former tenant could not afford to pay a judgment anyway.
Read More...
-
Posted
Apr 06 2009, 06:40 PM
by
Andrew Horowitz
Rating:
Money Blog: Top Stocks Blog - MSN Money
 The first quarter has come to a close and earnings season is upon us. Today marks the first official day of earnings with major reports from Alcoa (AA), Chattem (CHTT), Bed Bath & Beyond (BBBY) and Mosaic (MOS).
Mosaic and Alcoa are both facing a major headwind with commodities at rock bottom prices and deteriorating consumption. Alcoa has seen its share of decline as a worldwide miner of bauxite, producer of alumina and primary and fabricated aluminum. The Dow Jones AIG Aluminum Index has fallen from a high in July 2008 of just over $90 to today’s value just under $40. Alcoa’s price has reflected this drop in the value of aluminum with an 82% decline in the stock during the same period. Mosaic has seen similar troubles with grain commodities as they provide fertilizer for those crops. As the prices of wheat, corn and soybeans fall, farmers have less money to spend on growing or producing a more fruitful crop.
While many are hoping for a recovery, these two companies have not seen any significant change in demand, and that is required for the world to claim victory over this recession. Until the consumption of commodities increases, we are just inching along with no end in sight. Here is what we expect...
Read More...
-
Posted
Apr 19 2009, 08:10 PM
by
Louis Navellier
Rating:
Money Blog: Top Stocks Blog - MSN Money
Wall Street does a fantastic job of making the simple complex. The more Wall Street can confuse investors, the more dependent investors become on Wall Street for products and services. But the stock market is not really that complicated. If companies are growing, you can profit.
The key is to look at the business cycle. When the economy grows, business grows. That growth translates into stock values that go up. Now I like to find stocks that can make money even when their sectors aren't typically fueled by economic growth, like my 5 Hot Stocks in Ice-Cold Sectors. But it's equally as profitable to look to sectors that get a tailwind from economic activity. Technology is one of those sectors right now
Read More...
-
Posted
May 14 2009, 02:52 PM
by
Louis Navellier
Rating:
Money Blog: Top Stocks Blog - MSN Money
Wal-Mart (WMT) reported first-quarter earnings Thursday. On surface, the results don't appear to be that strong, but when you look at the details, I think Wal-Mart is doing quite well.
For the quarter, Wal-Mart earned $3.02 billion, which is the same as last year's first quarter. However, Wal-Mart has fewer outstanding shares, so the earnings per share increased from 76 cents to 77 cents.
See which other Fortune 500 stocks I recommend buying now.
The really telling part is that net sales fell 0.6% to $93.47 billion. But remember, Wal-Mart is an international company. The dollar was strong in the first quarter. If you exclude the impact of the currency exchange, Wal-Mart's sales would have actually increased 4.5%
Read More...
-
Posted
Jun 04 2009, 07:22 AM
by
Andrew Rosenbaum
Rating:
Money Blog: Top Stocks Blog - MSN Money
Stock markets in emerging markets like India, China, Brazil and Peru are booming. Their success makes the much-touted three-month rally on U.S. markets look like a tame fizzle.
India's Nifty Stock Index has increased 64% in the past three months. Brazil's Bovespa has advanced 41%. Russia RTS Index is up 90%!
Meanwhile the Dow Jones Industrial Average has risen a mere 28% in the same period. Where would you put your money?
Read More...
-
Posted
May 01 2009, 12:48 PM
by
Minyanville
Rating:
Money Blog: Top Stocks Blog - MSN Money
Shares of Molson Coors (TAP) were up over $1.70 or 4.5% to $38.45 yesterday, and its options have traded at 4 times the average daily volume. A good portion of that was in the June $40 call, which saw 2,019 contracts trade at the $1.25 asking price.
Prior open interest in the strike was 2089 contract; this was an opening sale. It appears to be tied to stock as part of buy-write. The sale pushed IV down 10 percentage point s on the day, even as the company’s earnings are slated for release next Tuesday, May 5.
The David in publicly traded brewers, Sam Adams (SAM), also saw a pop in its share price, up some 1.20 or 4% yesterday and over 16% over the past 3 trading days. But its options lack any fizz. There was a big purchase of calls back in late March which is proving to be well-bought; no notable volume has occurred in the past 3 weeks.
Read More...
-
Posted
Jul 06 2009, 09:56 AM
by
Catherine Holahan
Rating:
Money Blog: Top Stocks Blog - MSN Money
 Michael Jackson had plenty of fans among investors. But, many are now discovering that a bet on the global icon's fame and future earning power was a far riskier proposition than they had believed.
The iconic performer's death has reportedly left financial firms such as Colony Capital, Fortress Investment Group and Barclays Bank in creditor's limbo, according to a recent Associated Press article. Jackson reportedly had $331 million in outstanding debts when he died, but had assets totaling more than $567 million.
The financial firms, some of which lent Jackson money on the belief that he could easily pay them back with revenue made from future tours and music sales, are now awaiting the division of his estate. Today, a Los Angeles judge ruled that Jackson's attorney and friend John Branca should oversee the distribution of Jackson's remaining assets.
While some investors are only hoping to be paid back, others are undoubtedly hoping to profit from the singer's death. Assets such as the singer's music catalog and Neverland ranch could be worth far more overtime than their current selling price. The ranch, in particular, is more valuable than the now depressed value of its California land would indicate.
Read More...
-
Posted
Jul 08 2009, 01:34 PM
by
Anthony Mirhaydari
Rating:
Money Blog: Top Stocks Blog - MSN Money
There's nothing quite like earnings season. Three months of hope and fear condensed into the span of a few weeks as executives open the veil and let investors have a look. With Alcoa (AA) kicking things off Wednesday afternoon with an earnings beat (-26 cents per share against a -38 cent estimate), everyone is looking for signs the economy has truly begun the long march to recovery.
Unfortunately, with earnings expectations already pricing in a rather optimistic scenario, the results will likely disappoint.
While earnings estimates were slashed as the last two quarters rolled on, estimates for the second quarter have only decreased slightly since March. In fact, earnings expectations have actually increased slightly since bottoming back in May. In other words, stock analysts have become more confident not just in the economy's health, but in their own forecasts as well.
Read More...
-
Posted
Jul 15 2009, 11:56 AM
by
Catherine Holahan
Rating:
Money Blog: Top Stocks Blog - MSN Money
 As strapped consumers look for ways to save, they are increasingly turning to generic products. Savvy investors still have time to add generic manufacturers to their portfolios and profit from the downturn.
The desire for generics over name-brand drugs was evident in recent earnings reports from pharmaceutical giants and consumer products companies. This week, Johnson & Johnson, which manufactures products as varies as Neutrogena skin care products and brand name birth control pills, said sales dropped 7.4% in second quarter to $15.2 billion. Company executives attributed the decline largely to competition from generic drug makers, who sell alternatives to J&J's leading drugs, such as anti-psychotic Risperdal.
"Our pharmaceutical business saw the continued impact of generic competition," said Dominic Caruso, J&J's chief financial officer, during the company's July 14 earnings call.
Generic drugs had a similarly negative impact on Abbott Laboratories. The Chicago-based drug-maker said today that its prescription drugs sales fell 4.3% to $3.95 billion due in part to generic competition for anti-depressant Depakote.
Meanwhile, smaller generic drug developers saw their sales soar this quarter. Hi-Tech Pharmacal, a generic drug manufacturer based in Amityville, N.Y., said July 14 that its sales rose 82% in the most recent quarter to $38.3 million. The surge was primarily due to sales of generic drugs, such as its Dorzolamide anti-glaucoma treatment. The company's profits increased 18 times, from $277,000 to $5.1 million.
Investors interested in profiting from consumers trading to generics will want to take a look at Teva Pharmaceutical Industries and Mylan Labs.
Read More...
More Posts Next page »
|
